These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Idée JM; Port M; Medina C; Lancelot E; Fayoux E; Ballet S; Corot C Toxicology; 2008 Jun; 248(2-3):77-88. PubMed ID: 18440117 [TBL] [Abstract][Full Text] [Related]
27. [Nephrogenic systemic fibrosis and gadolinium-based contrast media]. Andréjak M; Thuillier D; Lok C; Gras-Champel V Therapie; 2007; 62(2):169-72. PubMed ID: 17582319 [TBL] [Abstract][Full Text] [Related]
28. Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors. Khurana A; Greene JF; High WA J Am Acad Dermatol; 2008 Aug; 59(2):218-24. PubMed ID: 18538448 [TBL] [Abstract][Full Text] [Related]
29. [Nephrogenic systemic fibrosis and gadolinium-containing contrast agents: what imaging for chronic kidney failure patients?]. Ignace S; Juillard L Nephrol Ther; 2007 Jul; 3(4):123-5. PubMed ID: 17658437 [No Abstract] [Full Text] [Related]
30. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. Abraham JL; Thakral C Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532 [TBL] [Abstract][Full Text] [Related]
31. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients. Khurram M; Skov L; Rossen K; Thomsen HS; Marckmann P Scand J Urol Nephrol; 2007; 41(6):565-6. PubMed ID: 17934986 [TBL] [Abstract][Full Text] [Related]
34. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure]. Michelet PR; Chopard CS; Martin PY; Vallée JP Rev Med Suisse; 2008 Mar; 4(147):576-8, 580. PubMed ID: 18402015 [TBL] [Abstract][Full Text] [Related]
35. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Deo A; Fogel M; Cowper SE Clin J Am Soc Nephrol; 2007 Mar; 2(2):264-7. PubMed ID: 17699423 [TBL] [Abstract][Full Text] [Related]
36. Nephrogenic systemic fibrosis. Nainani N; Panesar M Am J Nephrol; 2009; 29(1):1-9. PubMed ID: 18663283 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure. Todd DJ; Kagan A; Chibnik LB; Kay J Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148 [TBL] [Abstract][Full Text] [Related]
38. What nephrogenic fibrosing dermopathy might be. LeBoit PE Arch Dermatol; 2003 Jul; 139(7):928-30. PubMed ID: 12873893 [No Abstract] [Full Text] [Related]
39. Nephrogenic systemic fibrosis: is gadolinium to be blamed? Jikki PN J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697 [No Abstract] [Full Text] [Related]